The Role of Congenital Mucosal Immune System in the Airways of Patients With Chronic Obstructive Pulmonary Disease

NCT04061122 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2019-08-19

No results posted yet for this study

Summary

The purpose of the study is to explore the role of congenital mucosal immune system in the airways of patients with COPD including the impact of ILCs (Innate lymphoid cells) on metabolism of epithelial cells.During the research the following methods will be applied: measurement of Volatile Organic Compounds (VOCS), airway epithelial cytology and culture.

Conditions

  • COPD Exacerbation
  • Smoking, Tobacco

Interventions

DIAGNOSTIC_TEST

airway epithelial smear test

all patients will be subjected to all scheduled procedures: airways epithelial smear test, measurement of VOCs in exhaled air and airways slide sample culture

Sponsors & Collaborators

  • Medical University of Lodz

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-04
Primary Completion
2020-01-30
Completion
2020-06-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04061122 on ClinicalTrials.gov